Characteristics and antidepressant treatment outcomes of patients with psychogenic movement disorder: A naturalistic study

被引：0
|
作者：
Voon, V
Lang, AE
机构：
来源：
MOVEMENT DISORDERS | 2005年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P203
引用
收藏
页码：S61 / S61
页数：1
相关论文
共 50 条
  • [21] Countertransference, alliance, and outcome in the treatment of patients with personality disorder: a longitudinal naturalistic study
    Ovstebo, Randi Breivik
    Pedersen, Geir
    Wilberg, Theresa
    Rossberg, Jan Ivar
    Dahl, Hanne-Sofie Johnsen
    Kvarstein, Elfrida Hartveit
    FRONTIERS IN PSYCHIATRY, 2024, 15
  • [22] PROBLEMS WITH TRICYCLIC ANTIDEPRESSANT USE IN PATIENTS WITH PANIC DISORDER OR AGORAPHOBIA - RESULTS OF A NATURALISTIC FOLLOW-UP-STUDY
    NOYES, R
    GARVEY, MJ
    COOK, BL
    SAMUELSON, L
    JOURNAL OF CLINICAL PSYCHIATRY, 1989, 50 (05) : 163 - 169
  • [23] Gender differences in 12-week antidepressant treatment outcomes for a naturalistic secondary care cohort: The CRESCEND study
    Yang, Su-Jin
    Kim, Sun-Young
    Stewart, Robert
    Kim, Jae-Min
    Shin, Il-Seon
    Jung, Sung-Won
    Lee, Min-Soo
    Jeong, Seung-Hee
    Jun, Tae-Youn
    PSYCHIATRY RESEARCH, 2011, 189 (01) : 82 - 90
  • [24] Cognitive-Behavioral Treatment of Obsessive-Compulsive Disorder: The Results of a Naturalistic Outcomes Study
    Gragnani, Andrea
    Zaccari, Vittoria
    Femia, Giuseppe
    Pellegrini, Valerio
    Tenore, Katia
    Fadda, Stefania
    Luppino, Olga Ines
    Basile, Barbara
    Cosentino, Teresa
    Perdighe, Claudia
    Romano, Giuseppe
    Saliani, Angelo Maria
    Mancini, Francesco
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (10)
  • [25] Characteristics of Psychogenic Pruritus or Functional Itch Disorder: A Controlled Study
    Ferreira, Barbara R.
    Misery, Laurent
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [26] Migraine treatment outcomes with rizatriptan in triptan-naive patients: A naturalistic study
    Solomon, S
    Frishberg, B
    Hu, XH
    Markson, L
    Berger, M
    CLINICAL THERAPEUTICS, 2001, 23 (06) : 886 - 900
  • [27] Zuranolone in the Treatment of Major Depressive Disorder in Patients ≥65 Years of Age: Outcomes From the Phase 3, Naturalistic SHORELINE Study
    Cutler, Andrew
    Aaronson, Scott T.
    Mattingly, Gregory W.
    Wilkinson, Samuel T.
    Lasser, Robert
    Nandy, Indrani
    Rana, Nilanjana
    Brown, Colville
    Kanes, Stephen J.
    Doherty, James
    NEUROPSYCHOPHARMACOLOGY, 2021, 46 (SUPPL 1) : 214 - 215
  • [28] A retrospective naturalistic study on the psychopharmacological treatment of schizoaffective disorder
    Munoz-Negro, Jose E.
    Aguado Bailon, Lidia
    Calvo Rivera, Pilar
    Cervilla, Jorge A.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021, 36 (05) : 257 - 263
  • [29] Ethyl loflazepate as a treatment for patients with idiopathic and psychogenic taste disorder
    Ken-ichiro Sakata
    Hiroyuki Hato
    Jun Sato
    Takashi Iori
    Noritaka Ohga
    Haruhisa Watanabe
    Yutaka Yamazaki
    Yoshimasa Kitagawa
    BioPsychoSocial Medicine, 16
  • [30] Prospective study of antidepressant treatment of psychiatric patients with depressive disorders: treatment adequacy and outcomes
    von Knorring, Johanna
    Baryshnikov, Ilya
    Jylha, Pekka
    Talaslahti, Tiina
    Heikkinen, Martti
    Isometsa, Erkki
    BMC PSYCHIATRY, 2023, 23 (01)
12345